Pioneering Indian hospital treats 10,000th patient with Varian's RapidArc
Varian Medical Systems to Equip Proton Therapy Center in Netherlands
Research and Markets: South America Portable X Ray Devices Market - Growth, Trends And Forecasts (2014 - 2019)
Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.
Varian Medical Systems' VAR third-quarter results were in line with our expectations, and we are leaving our fair value estimate unchanged. Overall, revenue increased 7%, and net orders rose 13%, bringing the company's backlog at quarter-end to $1.6 billion. Revenue for the oncology system segment ...
While the sector looks slightly overvalued overall, we still see several stocks that offer attractive valuations across the different industries.
Varian Medical's VAR third-quarter fiscal 2006 results fall right in line with the seasonal patterns we expected from our current near-term modeling assumptions. The oncology group notched 14% growth, and customer demand continues to reflect a shift toward Varian's next-generation IGRT technology, ...
The combination makes plenty of sense and should better position the firm for the future.